Cathay Biotech Inc. (SHA:688065)
China · Delayed Price · Currency is CNY 41.42
-1.00 (-2.36%)
Sep 4, 2026, 3:00 PM CST
Cathay Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,298 | 9,252 | 5,347 | 5,390 | 6,295 | 9,629 |
Trading Asset Securities | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Cash & Short-Term Investments | 9,298 | 9,252 | 5,347 | 5,391 | 6,295 | 9,629 |
Cash Growth | -5.34% | 73.02% | -0.81% | -14.37% | -34.62% | 36.78% |
Accounts Receivable | 602.18 | 519.81 | 459.88 | 385.52 | 463.56 | 275.22 |
Other Receivables | 3.45 | 7.77 | 10.56 | 10.35 | 11.79 | 6.58 |
Receivables | 605.63 | 527.58 | 470.43 | 395.88 | 475.35 | 281.8 |
Inventory | 1,407 | 1,440 | 1,181 | 1,466 | 1,574 | 1,185 |
Prepaid Expenses | - | 0.64 | 7.29 | 10.57 | - | - |
Other Current Assets | 652.93 | 511.02 | 381.4 | 307.18 | 131.44 | 298.68 |
Total Current Assets | 11,963 | 11,731 | 7,387 | 7,571 | 8,475 | 11,395 |
Property, Plant & Equipment | 10,423 | 10,255 | 9,849 | 9,376 | 6,670 | 2,969 |
Long-Term Investments | 194.61 | 203.67 | 133.78 | 142.73 | 49.51 | 53.21 |
Other Intangible Assets | 748.74 | 728.5 | 685.04 | 703.85 | 777.87 | 768.46 |
Long-Term Deferred Tax Assets | 285.89 | 278.12 | 210.37 | 158.88 | 88.28 | 52.2 |
Long-Term Deferred Charges | 3.37 | 3.21 | 6.42 | 4.98 | 7.17 | 9.58 |
Other Long-Term Assets | 755 | 682.61 | 750.4 | 876.48 | 1,759 | 938.51 |
Total Assets | 24,612 | 23,882 | 19,021 | 18,833 | 17,827 | 16,185 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,375 | 207.08 | 135.44 | 167.85 | 240.08 | 248.83 |
Accrued Expenses | 14.4 | 30.77 | 30.32 | 21.54 | 32.47 | 42.34 |
Short-Term Debt | 294.04 | 301.22 | 1,247 | 746.25 | 161.47 | 743.51 |
Current Portion of Long-Term Debt | 36.15 | 12.81 | 37.17 | 784.37 | 5.38 | - |
Current Income Taxes Payable | 34.67 | 31.32 | 32.94 | 55.54 | 30.7 | 45.4 |
Current Unearned Revenue | 26.73 | 30.61 | 35.81 | 10.48 | 17.81 | 14.64 |
Other Current Liabilities | 498.44 | 1,393 | 1,399 | 1,624 | 936.28 | 123.01 |
Total Current Liabilities | 2,279 | 2,006 | 2,918 | 3,410 | 1,424 | 1,218 |
Long-Term Debt | 377.51 | 188.96 | 613.26 | 245.33 | 960.5 | - |
Long-Term Unearned Revenue | 360.2 | 371.98 | 389.29 | 405.18 | 404.39 | 293.03 |
Long-Term Deferred Tax Liabilities | 7.12 | - | - | - | - | - |
Total Liabilities | 3,024 | 2,567 | 3,920 | 4,060 | 2,789 | 1,511 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 721.29 | 721.29 | 583.38 | 583.38 | 583.28 | 416.68 |
Additional Paid-In Capital | 14,255 | 14,246 | 8,520 | 8,526 | 8,540 | 8,688 |
Retained Earnings | 2,867 | 2,819 | 2,546 | 2,167 | 1,905 | 1,539 |
Treasury Stock | -109.06 | -109.06 | -155.13 | -126.19 | -94.67 | - |
Comprehensive Income & Other | 26.52 | 23.17 | 12.77 | 14.45 | 14.69 | 8.23 |
Total Common Equity | 17,761 | 17,700 | 11,507 | 11,164 | 10,949 | 10,652 |
Minority Interest | 3,827 | 3,615 | 3,594 | 3,609 | 4,089 | 4,022 |
Shareholders' Equity | 21,588 | 21,315 | 15,101 | 14,773 | 15,038 | 14,674 |
Total Liabilities & Equity | 24,612 | 23,882 | 19,021 | 18,833 | 17,827 | 16,185 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 707.7 | 503 | 1,897 | 1,776 | 1,127 | 743.51 |
Net Cash (Debt) | 8,591 | 8,749 | 3,450 | 3,615 | 5,168 | 8,886 |
Net Cash Growth | -7.31% | 153.60% | -4.56% | -30.05% | -41.84% | 26.22% |
Net Cash Per Share | 12.03 | 12.79 | 5.93 | 6.21 | 8.87 | 15.24 |
Filing Date Shares Outstanding | 713.07 | 720.09 | 718.95 | 581.32 | 582.15 | 583.35 |
Total Common Shares Outstanding | 713.07 | 720.09 | 582.75 | 581.68 | 582.15 | 583.35 |
Working Capital | 9,684 | 9,725 | 4,469 | 4,161 | 7,051 | 10,177 |
Book Value Per Share | 24.91 | 24.58 | 19.75 | 19.19 | 18.81 | 18.26 |
Tangible Book Value | 16,775 | 16,971 | 10,822 | 10,460 | 10,171 | 9,883 |
Tangible Book Value Per Share | 23.52 | 23.57 | 18.57 | 17.98 | 17.47 | 16.94 |
Buildings | - | 1,963 | 1,958 | 1,815 | 1,357 | 988.18 |
Machinery | - | 3,360 | 3,330 | 3,216 | 2,979 | 1,807 |
Construction In Progress | - | 6,601 | 5,949 | 5,443 | 3,164 | 758.31 |